BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15316405)

  • 21. Extraesophageal symptoms of GERD.
    DeVault KR
    Cleve Clin J Med; 2003 Nov; 70 Suppl 5():S20-32. PubMed ID: 14705379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On respiratory manifestations of gastroesophageal reflux disease.
    Abrosimov VN; Ponomareva IB; Nizov AA; Solodun MV
    Ter Arkh; 2018 Aug; 90(8):131-136. PubMed ID: 30701948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between gastro-oesophageal reflux and airway diseases: the airway reflux paradigm.
    Pacheco-Galván A; Hart SP; Morice AH
    Arch Bronconeumol; 2011 Apr; 47(4):195-203. PubMed ID: 21459504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acid suppression in gastro-oesophageal reflux disease: Why? How? How much and when?
    Jones MP
    Postgrad Med J; 2002 Aug; 78(922):465-8. PubMed ID: 12185218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct comparative trials of the efficacy of proton pump inhibitors in the management of gastro-oesophageal reflux disease and peptic ulcer disease.
    Vakil N; Fennerty MB
    Aliment Pharmacol Ther; 2003 Sep; 18(6):559-68. PubMed ID: 12969082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastroesophageal reflux disease.
    Kahrilas PJ
    JAMA; 1996 Sep; 276(12):983-8. PubMed ID: 8805734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the effects of esomeprazole and fundoplication on airway responsiveness in patients with gastro-oesophageal reflux disease.
    Kiljander T; Rantanen T; Kellokumpu I; Kööbi T; Lammi L; Nieminen M; Poussa T; Ranta A; Saarelainen S; Salminen P
    Clin Respir J; 2013 Jul; 7(3):281-7. PubMed ID: 23006321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Application of the recommendations of the conference of consensus in front of symptoms ENT, respiratory or thoracic pains considered as due to a gastroesophageal reflux disease].
    Vallot T; Ducrotte P; Bour B; Jacques JP; Houcke P; De Korwin JD; Pariente A; Aygalenq P; Coudsy B; Carrois F; Ricci L; Bruley des Varannes S
    Presse Med; 2013 May; 42(5):e125-32. PubMed ID: 23414966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Night-time gastro-oesophageal reflux disease: prevalence, hazards, and management.
    Orr WC
    Eur J Gastroenterol Hepatol; 2005 Jan; 17(1):113-20. PubMed ID: 15647651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
    Miner PB
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic cough--about a clinical case..
    Fonseca G
    Clin Drug Investig; 2009; 29 Suppl 2():19-22. PubMed ID: 19938883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapy Insight: gastroesophageal reflux disease and laryngopharyngeal reflux.
    Vaezi MF
    Nat Clin Pract Gastroenterol Hepatol; 2005 Dec; 2(12):595-603. PubMed ID: 16327839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review article: current practice and future perspectives in the management of gastro-oesophageal reflux disease.
    Lambert R
    Aliment Pharmacol Ther; 1997 Aug; 11(4):651-62. PubMed ID: 9305472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharyngo-laryngeal consequences of gastroesophageal reflux. Value of esophageal pH measurements in 74 patients].
    De Ronde T; Melange M; Remacle M; Bertrand B
    Acta Gastroenterol Belg; 1991; 54(2):169-75. PubMed ID: 1755269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is ambulatory 24-h dual-probe pH monitoring useful in suspected ENT manifestations of GERD?
    Sermon F; Vanden Brande S; Roosens B; Mana F; Deron P; Urbain D
    Dig Liver Dis; 2004 Feb; 36(2):105-10. PubMed ID: 15002816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of broncopulmonary and otorhinolaryngologic symptoms in children under investigation for gastroesophageal reflux disease: retrospective analysis.
    Santos VJ; Comes GT; Gonçalves TM; Carvalho Mde A; Weber SA
    Braz J Otorhinolaryngol; 2011 Jun; 77(3):328-33. PubMed ID: 21739007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton pump inhibitor use and enteric infections.
    Dial MS
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S10-6. PubMed ID: 19262540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease.
    Kahrilas PJ; Hughes N; Howden CW
    Gut; 2011 Nov; 60(11):1473-8. PubMed ID: 21508423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should upper gastrointestinal endoscopy be part of the evaluation for supraesophageal symptoms of GERD?
    DeVault KR
    Am J Gastroenterol; 2004 Aug; 99(8):1427-9. PubMed ID: 15307854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acid reflux management: ENT perspective.
    Ahmad I; Batch AJ
    J Laryngol Otol; 2004 Jan; 118(1):25-30. PubMed ID: 14979968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.